These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8758533)

  • 21. [Successful desensitization using cisplatin after carboplatin-associated hypersensitivity reactions in 3 cases with recurrent ovarian carcinoma].
    Hosaka M; Ebina Y; Moriwaki M; Hara Y; Araki N; Todo Y; Takeda M; Watari H; Sakuragi N
    Gan To Kagaku Ryoho; 2007 Sep; 34(9):1505-8. PubMed ID: 17876157
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Usefulness of skin testing with platinum salts to demonstrate lack of cross-reactivity between carboplatin and cisplatin.
    Enrique E; Malek T; Castelló JV; de Mateo JA
    Ann Allergy Asthma Immunol; 2008 Jan; 100(1):86. PubMed ID: 18254488
    [No Abstract]   [Full Text] [Related]  

  • 23. Symptomatic hypocalcemia and hypomagnesiemia in cisplatinum-based chemotherapy treated patients: case report.
    Maina A; Richiardi G; Danese S; Defabiani E; Giardina G
    Eur J Gynaecol Oncol; 1996; 17(4):281-2. PubMed ID: 8856305
    [No Abstract]   [Full Text] [Related]  

  • 24. Hypomagnesemic hypocalcemia secondary to renal magnesium wasting.
    Bar RS; Wilson HE; Mazzaferri EL
    Ann Intern Med; 1975 May; 82(5):646-9. PubMed ID: 1137260
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk of leukemia after platinum-based chemotherapy for ovarian cancer.
    Travis LB; Holowaty EJ; Bergfeldt K; Lynch CF; Kohler BA; Wiklund T; Curtis RE; Hall P; Andersson M; Pukkala E; Sturgeon J; Stovall M
    N Engl J Med; 1999 Feb; 340(5):351-7. PubMed ID: 9929525
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Renal magnesium wasting, hypomagnesemic hypocalcemia, hypocalciuria and osteopenia in a patient with glycogenosis type II.
    Oktenli C
    Am J Nephrol; 2000; 20(5):412-7. PubMed ID: 11093001
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Primary hypomagnesemia with secondary hypocalcemia. Report of a case and review of the world literature.
    Yamamoto T; Kabata H; Yagi R; Takashima M; Itokawa Y
    Magnesium; 1985; 4(2-3):153-64. PubMed ID: 2995735
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypocalcemia and hypomagnesemia after ibuprofen overdose.
    al-Harbi NN; Domrongkitchaiporn S; Lirenman DS
    Ann Pharmacother; 1997 Apr; 31(4):432-4. PubMed ID: 9101004
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypomagnesemic hypocalcemia in chronic renal failure.
    Torralbo A; Portoles J; Perez Perez AJ; Barrientos A
    Am J Kidney Dis; 1993 Feb; 21(2):167-71. PubMed ID: 8430677
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proton pump inhibitors and symptomatic hypomagnesemic hypoparathyroidism.
    Fatuzzo P; Portale G; Scollo V; Zanoli L; Granata A
    J Nephrol; 2017 Apr; 30(2):297-301. PubMed ID: 27206762
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Magnesium protects against cisplatin-induced acute kidney injury without compromising cisplatin-mediated killing of an ovarian tumor xenograft in mice.
    Solanki MH; Chatterjee PK; Xue X; Gupta M; Rosales I; Yeboah MM; Kohn N; Metz CN
    Am J Physiol Renal Physiol; 2015 Jul; 309(1):F35-47. PubMed ID: 25947343
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Persistent nephrotoxicity during 10-year follow-up after cisplatin or carboplatin treatment in childhood: relevance of age and dose as risk factors.
    Skinner R; Parry A; Price L; Cole M; Craft AW; Pearson AD
    Eur J Cancer; 2009 Dec; 45(18):3213-9. PubMed ID: 19850470
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Periocular chemotherapy for retinoblastoma: success with problems?
    Abramson DH
    Arch Ophthalmol; 2005 Jan; 123(1):128-9; author reply 129. PubMed ID: 15642840
    [No Abstract]   [Full Text] [Related]  

  • 34. Prophylaxis against hypomagnesaemia induced by cis-platinum combination chemotherapy.
    Macaulay VM; Begent RH; Phillips ME; Newlands ES
    Cancer Chemother Pharmacol; 1982; 9(3):179-81. PubMed ID: 6891627
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Natural history and outcome of neonatal hypocalcemic and hypomagnesemic seizures.
    Lynch BJ; Rust RS
    Pediatr Neurol; 1994 Jul; 11(1):23-7. PubMed ID: 7986288
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical predictors associated with proton pump inhibitor-induced hypomagnesemia.
    Kim S; Lee H; Park CH; Shim CN; Lee HJ; Park JC; Shin SK; Lee SK; Lee YC; Kim HY; Kang DR
    Am J Ther; 2015; 22(1):14-21. PubMed ID: 23846522
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cisplatin administration following carboplatin desensitization failure in primary peritoneal cancer: a brief report.
    Greene DP; Ferriss JS; Jazaeri AA
    Cancer Chemother Pharmacol; 2010 Jul; 66(2):265-7. PubMed ID: 19844714
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Hypomagnesemia in patients of gynecologic neoplasms following chemotherapy with cisplatin].
    Li L; Huang W; Zhu B
    Zhonghua Fu Chan Ke Za Zhi; 1995 Jun; 30(6):363-5. PubMed ID: 7555373
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pathogenesis of hypocalcemia in primary hypomagnesemia: normal end-organ responsiveness to parathyroid hormone, impaired parathyroid gland function.
    Suh SM; Tashjian AH; Matsuo N; Parkinson DK; Fraser D
    J Clin Invest; 1973 Jan; 52(1):153-60. PubMed ID: 4345201
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical analysis of hypersensitivity reaction of platinum in ovarian cancer and cervical cancer patients].
    Li L; Wu M; Yang JX; Wan XR; Huang HF; Pan LY; Shen K; Lang JH; Xiang Y
    Zhonghua Fu Chan Ke Za Zhi; 2016 Nov; 51(11):825-831. PubMed ID: 27916065
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.